Watch the presentation from the webinar.
Latest news
-
Oxcia AB (”Oxcia”) har idag offentliggjort årsredovisningen för 2021.
-
Aktieägarna i Oxcia AB (publ), org.nr 556932–4717, (”Bolaget”) kallas till årsstämma tisdagen den 14 juni 2022 klockan 17:00 i Life city, Solnavägen 3, Solna.
-
Oxcia AB is pioneering novel DNA Damage Response (DDR) and oxidative stress target drug development, researching solutions for patients suffering from diseases caused by cancer and inflammation. The company’s product portfolio consists of two drug candidates, of which one is… Continue reading Translational Scientist/Director to Oxcia AB